Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
Open-market buys, last 90 days
$35,023,032
in 1 filing
Open-market sales, last 90 days
$7,011,938
in 3 filings, $6.7M under 10b5-1 plans

Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. BAKER BROS. ADVISORS LP +$35.0M Director 1 filing
  2. Sibold William John −$6.2M President and CEO sold 6% of stake
  3. Kelley Shannon T −$773K General Counsel sold 14% of stake
Date Insider Transaction Shares Price Value Owned after
2021-12-03 BAY CITY CAPITAL LLC 10% owner Other disposition −750,270 1,510,521
2021-12-03 BAY CITY CAPITAL LLC 10% owner Other disposition −49,730 0
2021-12-03 BAY CITY CAPITAL LLC 10% owner Other disposition −24,172 1,261
2021-12-03 CRAVES FRED B Director Other disposition −750,270 1,510,521
2021-12-03 CRAVES FRED B Director Other disposition −49,730 0
2021-12-03 CRAVES FRED B Director Other disposition −24,172 1,261
2021-11-01 Howarth Alex G. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +5,000 5,000
2021-08-02 Waltermire Robert E. Senior VP, Chief Pharma Dev. Grant or award · Call Option +35,000 35,000
2021-06-17 Daly James M Director Grant or award · Stock Option (Right to Buy) +12,489 12,489
2021-06-17 CRAVES FRED B Director Grant or award · Stock Option (Right to Buy) +12,489 12,489
2021-06-17 MILLIGAN DAVID V Director Grant or award · Stock Option (Right to buy) +12,489 12,489
2021-06-17 BATE KENNETH Director Grant or award · Stock Option (Right to Buy) +12,489 12,489
2021-06-17 Levy Richard S Director Grant or award · Stock Option (Right to buy) +12,489 12,489
2021-06-17 Gollust Keith R Director Grant or award · Stock Option (Right to Buy) +12,489 12,489
2021-05-17 Howarth Alex G. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +65,000 65,000
2021-02-22 FRIEDMAN PAUL A Chief Executive Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2021-02-22 Schneebaum Marc R Chief Financial Officer Grant or award · Stock Option (Right to Buy) +32,000 32,000
2021-02-22 Sukhija Remy Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +24,000 24,000
2021-02-22 Lynch Brian Joseph SVP and General Councel Grant or award · Stock Option (Right to Buy) +32,000 32,000
2021-02-22 Taub Rebecca See Remarks Grant or award · Stock Option (Right to Buy) +44,000 44,000

Page 52 of 82 · 1,629 trades